|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Ploeg M, Aben KK and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu H, Wang M and Zhang Z: Bladder cancer
epidemiology and genetic susceptibility. J Biomed Res. 27:170–178.
2013. View Article : Google Scholar
|
|
4
|
Cordon-Cardo C: Molecular alterations
associated with bladder cancer initiation and progression. Scand J
Urol Nephrol Suppl. 154–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin J, Spitz MR, Wang Y, et al:
Polymorphisms of folate metabolic genes and susceptibility to
bladder cancer: a case-control study. Carcinogenesis. 25:1639–1647.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rouissi K, Ouerhani S, Oliveira E, et al:
Polymorphisms in one-carbon metabolism pathway genes and risk for
bladder cancer in a Tunisian population. Cancer Genet Cytogenet.
195:43–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moore LE, Malats N, Rothman N, et al:
Polymorphisms in one-carbon metabolism and trans-sulfuration
pathway genes and susceptibility to bladder cancer. Int J Cancer.
120:2452–2458. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bailey LB: Folate, methyl-related
nutrients, alcohol, and the MTHFR 677C→T polymorphism affect cancer
risk: intake recommendations. J Nutr. 133(Suppl 1): S3748–S3753.
2003.PubMed/NCBI
|
|
9
|
Frosst P, Blom HJ, Milos R, et al: A
candidate genetic risk factor for vascular disease: a common
mutation in methylenetetrahydrofolate reductase. Nat Genet.
10:111–113. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weisberg I, Tran P, Christensen B, Sibani
S and Rozen R: A second genetic polymorphism in
methylenetetrahydrofolate reductase (MTHFR) associated with
decreased enzyme activity. Mol Genet Metab. 64:169–172. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yin G, Kono S, Toyomura K, et al:
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms
and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer
Sci. 95:908–913. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tong N, Fang Y, Li J, et al:
Methylenetetrahydrofolate reductase polymorphisms, serum
methylenetetrahydrofolate reductase levels, and risk of childhood
acute lymphoblastic leukemia in a Chinese population. Cancer Sci.
101:782–786. 2010. View Article : Google Scholar
|
|
13
|
Boccia S, Gianfagna F, Persiani R, et al:
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms
and susceptibility to gastric adenocarcinoma in an Italian
population. Biomarkers. 12:635–644. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galbiatti AL, Ruiz MT, Rodrigues JO, et
al: Polymorphisms and haplotypes in methylenetetrahydrofolate
reductase gene and head and neck squamous cell carcinoma risk. Mol
Biol Rep. 39:635–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
16
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kimura F, Florl AR, Steinhoff C, et al:
Polymorphic methyl group metabolism genes in patients with
transitional cell carcinoma of the urinary bladder. Mutat Res.
458:49–54. 2001.PubMed/NCBI
|
|
19
|
Moore LE, Wiencke JK, Bates MN, Zheng S,
Rey OA and Smith AH: Investigation of genetic polymorphisms and
smoking in a bladder cancer case-control study in Argentina. Cancer
Lett. 211:199–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sanyal S, Festa F, Sakano S, et al:
Polymorphisms in DNA repair and metabolic genes in bladder cancer.
Carcinogenesis. 25:729–734. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karagas MR, Park S, Nelson HH, et al:
Methylenetetrahydrofolate reductase (MTHFR) variants and bladder
cancer: a population-based case-control study. Int J Hyg Environ
Health. 208:321–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ouerhani S, Oliveira E, Marrakchi R, et
al: Methylenetetrahydrofolate reductase and methionine synthase
polymorphisms and risk of bladder cancer in a Tunisian population.
Cancer Genet Cytogenet. 176:48–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai DW, Liu XF, Bu RG, et al: Genetic
polymorphisms of MTHFR and aberrant promoter hypermethylation of
the RASSF1A gene in bladder cancer risk in a Chinese population. J
Int Med Res. 37:1882–1889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ouerhani S, Rouissi K, Marrakchi R, et al:
Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on
bladder cancer susceptibility in Tunisian population. Cancer Detect
Prev. 32:395–402. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang M, Zhu H, Fu G, Wang M and Zhang Z,
Lu Q, Wang S and Zhang Z: Polymorphisms of
methylenetetrahydrofolate reductase and methionine synthase genes
and bladder cancer risk: a case-control study with meta-analysis.
Clin Exp Med. 9:9–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chung CJ, Pu YS, Su CT, et al:
Polymorphisms in one-carbon metabolism pathway genes, urinary
arsenic profile, and urothelial carcinoma. Cancer Causes Control.
21:1605–1613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Safarinejad MR, Shafiei N and Safarinejad
S: Genetic susceptibility of methylenetetrahydrofolate reductase
(MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for
bladder transitional cell carcinoma in men. Med Oncol. 28(Suppl 1):
S398–S412. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hirschhorn JN, Lohmueller K, Byrne E and
Hirschhorn K: A comprehensive review of genetic association
studies. Genet Med. 4:45–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Munafo MR and Flint J: Meta-analysis of
genetic association studies. Trends Genet. 20:439–444. 2004.
View Article : Google Scholar : PubMed/NCBI
|
